Oncologists stress health literacy to expand clinical trial access

Medical experts are stressing that health literacy and trust are vital for expanding patient participation in cancer clinical trials, Oncodaily reported. Ruiling Yuan, an adjunct assistant professor at the Edward Via College of Osteopathic Medicine, highlighted the need for patients to understand trials alongside finding them. Yuan commended Joanna Metzner-Sadurski, an assistant professor at the same institution and founder of Oncology101.org, for her work in improving clinical trial awareness. [1]

Community oncologists face ongoing challenges due to limited public awareness, low health literacy, and restricted access to care, according to Oncodaily. Yuan noted that these barriers are particularly noticeable among community and rural populations, where education regarding medical research remains limited. [1]

Clinical trials are prospective biomedical or behavioral research studies conducted on human participants. They are designed to evaluate dosage, safety, and efficacy for new medical interventions or established treatments requiring further comparison. Such trials can only proceed after receiving approval from local health authorities or ethics committees that review the overall risk and benefit ratio. [3]

Efforts by educational organizations and healthcare leaders aim to bridge these gaps by promoting clear communication. Improving health literacy helps empower patients to make informed choices about participating in medical research. [1]